SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in vitro and ocular angiogenesis in vivo

Ocular angiogenesis is a major cause of severe vision loss, which can affect several parts of the eye, including the retina, choroid and cornea. Vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors have demonstrated great potential for treating ocular angiogenesis and SKLB1002 is a pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiu-Yang, Tao, Shu-Ya, Lu, Chang, Li, Jing-Jing, Li, Xiu-Miao, Yao, Jin, Jiang, Qin, Yan, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185286/
https://www.ncbi.nlm.nih.gov/pubmed/32323773
http://dx.doi.org/10.3892/mmr.2020.11056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185286/
https://www.ncbi.nlm.nih.gov/pubmed/32323773
http://dx.doi.org/10.3892/mmr.2020.11056

Ejemplares similares